EUROFINS SCIENTIFIC (ESF0.DE) Stock Fundamental Analysis

FRA:ESF0 • FR0014000MR3

67.36 EUR
-1.2 (-1.75%)
Last: Mar 2, 2026, 07:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ESF0. ESF0 was compared to 18 industry peers in the Life Sciences Tools & Services industry. ESF0 has an average financial health and profitability rating. ESF0 is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year ESF0 was profitable.
  • In the past year ESF0 had a positive cash flow from operations.
  • ESF0 had positive earnings in each of the past 5 years.
  • In the past 5 years ESF0 always reported a positive cash flow from operatings.
ESF0.DE Yearly Net Income VS EBIT VS OCF VS FCFESF0.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • ESF0 has a Return On Assets of 6.29%. This is in the better half of the industry: ESF0 outperforms 66.67% of its industry peers.
  • ESF0's Return On Equity of 15.21% is amongst the best of the industry. ESF0 outperforms 83.33% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 11.61%, ESF0 belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
Industry RankSector Rank
ROA 6.29%
ROE 15.21%
ROIC 11.61%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ESF0.DE Yearly ROA, ROE, ROICESF0.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • ESF0 has a Profit Margin (6.48%) which is in line with its industry peers.
  • ESF0's Profit Margin has declined in the last couple of years.
  • ESF0 has a worse Operating Margin (12.42%) than 66.67% of its industry peers.
  • In the last couple of years the Operating Margin of ESF0 has declined.
  • ESF0 has a Gross Margin of 22.25%. This is in the lower half of the industry: ESF0 underperforms 77.78% of its industry peers.
  • ESF0's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 12.42%
PM (TTM) 6.48%
GM 22.25%
OM growth 3Y-11.06%
OM growth 5Y-10.4%
PM growth 3Y-9.05%
PM growth 5Y-6.87%
GM growth 3Y-1.72%
GM growth 5Y-3.8%
ESF0.DE Yearly Profit, Operating, Gross MarginsESF0.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ESF0 is creating some value.
  • There is no outstanding debt for ESF0. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ESF0.DE Yearly Shares OutstandingESF0.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ESF0.DE Yearly Total Debt VS Total AssetsESF0.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 3.05 indicates that ESF0 is not in any danger for bankruptcy at the moment.
  • ESF0 has a Altman-Z score (3.05) which is in line with its industry peers.
  • ESF0 has a debt to FCF ratio of 5.14. This is a neutral value as ESF0 would need 5.14 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.14, ESF0 is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
  • A Debt/Equity ratio of 0.82 indicates that ESF0 is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.82, ESF0 perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 5.14
Altman-Z 3.05
ROIC/WACC1.31
WACC8.85%
ESF0.DE Yearly LT Debt VS Equity VS FCFESF0.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 1.09 indicates that ESF0 should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.09, ESF0 is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • A Quick Ratio of 1.03 indicates that ESF0 should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.03, ESF0 is in line with its industry, outperforming 55.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.03
ESF0.DE Yearly Current Assets VS Current LiabilitesESF0.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

  • ESF0 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.73%, which is quite good.
  • Measured over the past years, ESF0 shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.23% on average per year.
  • Looking at the last year, ESF0 shows a very strong growth in Revenue. The Revenue has grown by 53.32%.
  • ESF0 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.05% yearly.
EPS 1Y (TTM)12.73%
EPS 3Y-4.43%
EPS 5Y-0.23%
EPS Q2Q%6.78%
Revenue 1Y (TTM)53.32%
Revenue growth 3Y2.82%
Revenue growth 5Y6.05%
Sales Q2Q%4.3%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.24% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 6.98% on average over the next years.
EPS Next Y10.84%
EPS Next 2Y12.5%
EPS Next 3Y15.73%
EPS Next 5Y15.24%
Revenue Next Year4.81%
Revenue Next 2Y5.71%
Revenue Next 3Y6.11%
Revenue Next 5Y6.98%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ESF0.DE Yearly Revenue VS EstimatesESF0.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
ESF0.DE Yearly EPS VS EstimatesESF0.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 18.11, which indicates a rather expensive current valuation of ESF0.
  • Compared to the rest of the industry, the Price/Earnings ratio of ESF0 indicates a somewhat cheap valuation: ESF0 is cheaper than 77.78% of the companies listed in the same industry.
  • ESF0 is valuated rather cheaply when we compare the Price/Earnings ratio to 27.13, which is the current average of the S&P500 Index.
  • ESF0 is valuated correctly with a Price/Forward Earnings ratio of 16.67.
  • ESF0's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ESF0 is cheaper than 77.78% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.11, ESF0 is valued a bit cheaper.
Industry RankSector Rank
PE 18.11
Fwd PE 16.67
ESF0.DE Price Earnings VS Forward Price EarningsESF0.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ESF0 is valued cheaper than 88.89% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, ESF0 is valued cheaply inside the industry as 94.44% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.22
EV/EBITDA 8.13
ESF0.DE Per share dataESF0.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • ESF0's earnings are expected to grow with 15.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.67
PEG (5Y)N/A
EPS Next 2Y12.5%
EPS Next 3Y15.73%

5

5. Dividend

5.1 Amount

  • ESF0 has a Yearly Dividend Yield of 1.06%.
  • Compared to an average industry Dividend Yield of 0.44, ESF0 pays a better dividend. On top of this ESF0 pays more dividend than 83.33% of the companies listed in the same industry.
  • With a Dividend Yield of 1.06, ESF0 pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.06%

5.2 History

  • On average, the dividend of ESF0 grows each year by 16.51%, which is quite nice.
Dividend Growth(5Y)16.51%
Div Incr Years1
Div Non Decr Years1
ESF0.DE Yearly Dividends per shareESF0.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 15.92% of the earnings are spent on dividend by ESF0. This is a low number and sustainable payout ratio.
  • ESF0's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP15.92%
EPS Next 2Y12.5%
EPS Next 3Y15.73%
ESF0.DE Yearly Income VS Free CF VS DividendESF0.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
ESF0.DE Dividend Payout.ESF0.DE Dividend Payout, showing the Payout Ratio.ESF0.DE Dividend Payout.PayoutRetained Earnings

EUROFINS SCIENTIFIC

FRA:ESF0 (3/2/2026, 7:00:00 PM)

67.36

-1.2 (-1.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-29
Earnings (Next)04-22
Inst Owners35.61%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap12.27B
Revenue(TTM)10.66B
Net Income(TTM)691.00M
Analysts67
Price Target72.63 (7.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.06%
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP15.92%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.66%
PT rev (3m)12.21%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.87%
Revenue NY rev (3m)-0.87%
Valuation
Industry RankSector Rank
PE 18.11
Fwd PE 16.67
P/S 1.15
P/FCF 14.22
P/OCF 8.76
P/B 2.7
P/tB N/A
EV/EBITDA 8.13
EPS(TTM)3.72
EY5.52%
EPS(NY)4.04
Fwd EY6%
FCF(TTM)4.74
FCFY7.03%
OCF(TTM)7.69
OCFY11.41%
SpS58.51
BVpS24.95
TBVpS-4.41
PEG (NY)1.67
PEG (5Y)N/A
Graham Number45.69
Profitability
Industry RankSector Rank
ROA 6.29%
ROE 15.21%
ROCE 15.48%
ROIC 11.61%
ROICexc 12.8%
ROICexgc 41.1%
OM 12.42%
PM (TTM) 6.48%
GM 22.25%
FCFM 8.1%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-11.06%
OM growth 5Y-10.4%
PM growth 3Y-9.05%
PM growth 5Y-6.87%
GM growth 3Y-1.72%
GM growth 5Y-3.8%
F-Score6
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 5.14
Debt/EBITDA 1.9
Cap/Depr 85.24%
Cap/Sales 5.04%
Interest Coverage 11.51
Cash Conversion 71.65%
Profit Quality 124.89%
Current Ratio 1.09
Quick Ratio 1.03
Altman-Z 3.05
F-Score6
WACC8.85%
ROIC/WACC1.31
Cap/Depr(3y)81.48%
Cap/Depr(5y)89.24%
Cap/Sales(3y)7.8%
Cap/Sales(5y)8.16%
Profit Quality(3y)196.03%
Profit Quality(5y)160.87%
High Growth Momentum
Growth
EPS 1Y (TTM)12.73%
EPS 3Y-4.43%
EPS 5Y-0.23%
EPS Q2Q%6.78%
EPS Next Y10.84%
EPS Next 2Y12.5%
EPS Next 3Y15.73%
EPS Next 5Y15.24%
Revenue 1Y (TTM)53.32%
Revenue growth 3Y2.82%
Revenue growth 5Y6.05%
Sales Q2Q%4.3%
Revenue Next Year4.81%
Revenue Next 2Y5.71%
Revenue Next 3Y6.11%
Revenue Next 5Y6.98%
EBIT growth 1Y27.19%
EBIT growth 3Y-8.55%
EBIT growth 5Y-4.98%
EBIT Next Year81.37%
EBIT Next 3Y28.68%
EBIT Next 5Y24.21%
FCF growth 1Y9.17%
FCF growth 3Y21.94%
FCF growth 5Y-0.12%
OCF growth 1Y6.15%
OCF growth 3Y7.21%
OCF growth 5Y2.73%

EUROFINS SCIENTIFIC / ESF0.DE FAQ

What is the ChartMill fundamental rating of EUROFINS SCIENTIFIC (ESF0.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ESF0.DE.


What is the valuation status for ESF0 stock?

ChartMill assigns a valuation rating of 5 / 10 to EUROFINS SCIENTIFIC (ESF0.DE). This can be considered as Fairly Valued.


What is the profitability of ESF0 stock?

EUROFINS SCIENTIFIC (ESF0.DE) has a profitability rating of 4 / 10.


What are the PE and PB ratios of EUROFINS SCIENTIFIC (ESF0.DE) stock?

The Price/Earnings (PE) ratio for EUROFINS SCIENTIFIC (ESF0.DE) is 18.11 and the Price/Book (PB) ratio is 2.7.


How sustainable is the dividend of EUROFINS SCIENTIFIC (ESF0.DE) stock?

The dividend rating of EUROFINS SCIENTIFIC (ESF0.DE) is 5 / 10 and the dividend payout ratio is 15.92%.